Virginia Tech Corporate Research Center Archives · BioBuzz

Loading …

Blacksburg biotech company goes public, hopes to treat autoimmune diseases

<img width="300" height="300" alt="" data-srcset="https://biobuzz.io/wp-content/uploads/2021/02/Landos_1-300x300.jpg 300w, https://biobuzz.io/wp-content/uploads/2021/02/Landos_1-150x150.jpg 150w, https://biobuzz.io/wp-content/uploads/2021/02/Landos_1-75x75.jpg 75w" data-src="https://biobuzz.io/wp-content/uploads/2021/02/Landos_1-300x300.jpg" data-sizes="(max-width: 300px) 100vw, 300px" class="attachment-biobuzz-medium size-biobuzz-medium wp-post-image lazyload lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img width="300" height="300" src="https://biobuzz.io/wp-content/uploads/2021/02/Landos_1-300x300.jpg" class="attachment-biobuzz-medium size-biobuzz-medium wp-post-image lazyload" alt="" srcset="https://biobuzz.io/wp-content/uploads/2021/02/Landos_1-300x300.jpg 300w, https://biobuzz.io/wp-content/uploads/2021/02/Landos_1-150x150.jpg 150w, https://biobuzz.io/wp-content/uploads/2021/02/Landos_1-75x75.jpg 75w" sizes="(max-width: 300px) 100vw, 300px" />

Published on : February 11, 2021February 15, 2021 Published by : BioBuzz Media

Blacksburg biotech company Landos Biopharma Inc. has gone public. An initial public offering of stock, priced at $16 a share, was expected to raise $100 million to develop possible new [….]